List of Provigil drug patents
Provigil is owned by Cephalon.
Provigil contains Modafinil.
Provigil has a total of 2 drug patents out of which 0 drug patents have expired.
Provigil was authorised for market use on 24 December, 1998.
Provigil is available in tablet;oral dosage forms.
The generics of Provigil are possible to be released after 29 May, 2024.
| Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US7297346 | CEPHALON | Pharmaceutical formulations of modafinil |
Nov, 2023
(5 months from now) | |
|
US7297346 (Pediatric) | CEPHALON | Pharmaceutical formulations of modafinil |
May, 2024
(11 months from now) | |
Drugs and Companies using MODAFINIL ingredient
Market Authorisation Date: 24 December, 1998
Treatment: NA
Dosage: TABLET;ORAL
PROVIGIL family patents
7
United States
3
China
3
Japan
2
Canada
2
Korea, Republic of
2
Brazil
2
Hong Kong
2
Taiwan
2
Germany
2
Argentina
2
Spain
2
Mexico
2
New Zealand
2
Australia
2
Norway
2
South Africa
2
Austria
2
Israel
2
Malaysia
2
European Union
1
Poland
1
Slovenia
1
Ukraine
1
Iceland
1
Cyprus
1
Denmark
1
EA
1
Portugal
900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight
Join them to stay ahead in capturing the next drug going generic